Trial · NCT00090220
Participant flow84
How many started, completed or left each group, period by period.
21 to 40 of 84
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Base Study Vaccination Period | NOT COMPLETED | Placebo in Base Study: EXT1 | 0 | |
| Base Study Vaccination Period | NOT COMPLETED | Incomplete qHPV Regimen in Base Study: EXT1 | 0 | |
| Base Study Vaccination Period | NOT COMPLETED | qHPV Vaccine in Base Study: LTFU (EXT2) | 0 | |
| Base Study Vaccination Period | NOT COMPLETED | Placebo in Base Study and qHPV Vaccine in EXT1: LTFU (EXT2) | 0 | |
| Base Study Follow-up Period | STARTED | qHPV Vaccine in Base Study | 1,855 | |
| Base Study Follow-up Period | STARTED | Placebo in Base Study | 1,851 | |
| Base Study Follow-up Period | STARTED | Placebo in Base Study: EXT1 | 0 | |
| Base Study Follow-up Period | STARTED | Incomplete qHPV Regimen in Base Study: EXT1 | 0 | |
| Base Study Follow-up Period | STARTED | qHPV Vaccine in Base Study: LTFU (EXT2) | 0 | |
| Base Study Follow-up Period | STARTED | Placebo in Base Study and qHPV Vaccine in EXT1: LTFU (EXT2) | 0 | |
| Base Study Follow-up Period | COMPLETED | qHPV Vaccine in Base Study | 1,695 | |
| Base Study Follow-up Period | COMPLETED | Placebo in Base Study | 1,687 | |
| Base Study Follow-up Period | COMPLETED | Placebo in Base Study: EXT1 | 0 | |
| Base Study Follow-up Period | COMPLETED | Incomplete qHPV Regimen in Base Study: EXT1 | 0 | |
| Base Study Follow-up Period | COMPLETED | qHPV Vaccine in Base Study: LTFU (EXT2) | 0 | |
| Base Study Follow-up Period | COMPLETED | Placebo in Base Study and qHPV Vaccine in EXT1: LTFU (EXT2) | 0 | |
| Base Study Follow-up Period | NOT COMPLETED | qHPV Vaccine in Base Study | 160 | |
| Base Study Follow-up Period | NOT COMPLETED | Placebo in Base Study | 164 | |
| Base Study Follow-up Period | NOT COMPLETED | Placebo in Base Study: EXT1 | 0 | |
| Base Study Follow-up Period | NOT COMPLETED | Incomplete qHPV Regimen in Base Study: EXT1 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00090220/flow?page=2